A Clinical Study of CAR-T Treating Relapsed or Refractory T Cell Lymphoblastic Acute Leukemia/ Lymphoma
Guangzhou Bio-gene Technology Co., Ltd
Guangzhou Bio-gene Technology Co., Ltd
Gyala Therapeutics
Ossium Health, Inc.
Servier
Wugen, Inc.
Daiichi Sankyo
Otsuka Medical Devices Co., Ltd. Japan
Wugen, Inc.
Bristol-Myers Squibb
Tr1X, Inc.
Chongqing Precision Biotech Co., Ltd
Celgene
Boehringer Ingelheim
Wugen, Inc.
HUYABIO International, LLC.
Kyowa Kirin Co., Ltd.
Cellestia Biotech AG
Hebei Senlang Biotechnology Inc., Ltd.
Atara Biotherapeutics
Hebei Senlang Biotechnology Inc., Ltd.
Sanofi
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
miRagen Therapeutics, Inc.
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Eli Lilly and Company
Bristol-Myers Squibb
GlaxoSmithKline
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Progen Pharmaceuticals
Erimos Pharmaceuticals
Morphotek
Merck Sharp & Dohme LLC
GlaxoSmithKline
INSYS Therapeutics Inc
Mundipharma Research Limited